A phase II trial of cisplatin, pemetrexed and bevacizumab in untreated malignant mesothelioma.
Phase of Trial: Phase II
Latest Information Update: 09 Jan 2017
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin (Primary) ; Pemetrexed (Primary)
- Indications Mesothelioma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 16 Aug 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Jul 2006 New trial record.